Martine A. Rothblatt, Chairperson & CEO at UNITED THERAPEUTICS Corp (UTHR), sold 9,500 shares at $488.70 ($4.7M) on 2026-09-23, disclosed to the SEC on 2026-09-24.
Scheduled sale ($4.7M) by Chairperson & CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $488.70 | 2,388 | $1.2M | 25.0% |
| 2 | $489.52 | 2,162 | $1.1M | 22.7% |
| 3 | $490.48 | 1,440 | $706K | 15.1% |
| 4 | $491.65 | 824 | $405K | 8.7% |
| 5 | $492.54 | 480 | $236K | 5.1% |
| 6 | $493.72 | 160 |
| $79K |
| 1.7% |
| 7 | $495.17 | 155 | $77K | 1.6% |
| 8 | $496.38 | 525 | $261K | 5.6% |
| 9 | $497.27 | 766 | $381K | 8.2% |
| 10 | $498.38 | 270 | $135K | 2.9% |
| 11 | $498.90 | 90 | $45K | 1.0% |
| 12 | $500.05 | 240 | $120K | 2.6% |
| Total | $491.57 avg | 9,500 | $4.7M | 100% |
| Filing → |
| UTHR | SELL | 2026-10-07 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-06 | $5.1M | — | Filing → |
| UTHR | SELL | 2026-10-05 | $5.2M | — | Filing → |